Abstract
This market insight report on Biomarkers focuses on the different types of
biomarkers and their impact on various disease areas such as oncology,
neurology, cardiology and other areas including metabolomic turmoil,
arthritis, gynecology, oxidative stress, liver disease, pulmonary disease and
aging. The study provides global market analysis for biomarkers by the above
disease areas and also by prominent biomarker discovery technologies including
imaging, genomics, proteomics, metabolomics, bioinformatics and other
technologies comprising fluorescent indicators, lab-on-chip, nuclear magnetic
resonance, mass spectrometry/liquid chromatography and nanobiotechnology.
Though the report mentions about non-medical applications of biomarkers, the
study emphasizes only on the medical applications. The study includes
estimates and projections for the total global biomarkers market. The market
covered for genomics, proteomics and bioinformatics pertains only to biomarker
discovery applications. Projections and estimates figure for geographic
regions including United States, Europe, Japan, Asia-Pacific, Canada and Rest
of World. The industry is analyzed in US Dollars and includes 199 exclusive
exhibits. A total of 402 companies are covered that are engaged in biomarkers
R&D, discovery, testing, and supply of products and services.
View Cart
